Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial

BACKGROUND: Basal cell carcinoma (BCC) is a common skin cancer often curable by excision; however, for patients with BCC around the eye, excision places visual organs and function at risk. In this article, we test the hypothesis that use of the hedgehog inhibitor vismodegib will improve vision‐relat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Kahana, Alon, Unsworth, Shelby P., Andrews, Christopher A., Chan, May P., Bresler, Scott C., Bichakjian, Christopher K., Durham, Alison B., Demirci, Hakan, Elner, Victor M., Nelson, Christine C., Kim, Denise S., Joseph, Shannon S., Swiecicki, Paul L., Worden, Francis P.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2021
Assuntos:
Melanoma and Cutaneous Malignancies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265335/
https://ncbi.nlm.nih.gov/pubmed/33988881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13820
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados